CA
NZ
UK
AU
IND
US
The company also signaled that disciplined cost control will enable cash‑flow breakeven in the fourth quarter, a milestone that could unlock greater financial flexibility and appeal to value‑focused investors.
Schwartz's confirmation as director of the CDC marks a critical turnover in public health leadership, with potential ramifications for the healthcare sector. The Senate's decision follows intense debate regarding Schwartz's capability to navigate contentious health policy issues and the ongoing conflict concerning health authority …
CytomX Therapeutics (NASDAQ: CTMX) reported earnings that fell short of consensus expectations, posting an earnings miss while revenue shrank dramatically to $1.4 million from $18.7 million a year earlier. The company’s cash balance stands at $330.3 million, not counting a recent $37.0 million payment …
Doximity, Inc. (NYSE: DOCS) reported revenues totaling $156.6 million for the first quarter ending June 30, reflecting a 7% year-over-year increase, albeit slightly below the $0.31 consensus EPS estimate with a reported EPS of $0.29. This discrepancy highlights the market's cautious outlook regarding the …
Sandisk's stock soared 8% as the market reacted positively to burgeoning enthusiasm over AI-driven memory demand. Analysts highlighted an optimistic future for computer memory components owing to advancements in artificial intelligence technologies. This sentiment not only boosted Sandisk but also raised the profiles of …
FIGS, Inc. (NYSE: FIGS) delivered earnings of $0.11 per share for the quarter ended June 30, well above the $0.07 consensus, and simultaneously announced a $100 million boost to its share repurchase program, raising the ceiling to $200 million. Net revenues surged 28.8% to …
The strong performance led to an 18% surge in share prices, showcasing investor confidence in the company's unified platform strategy. Shop Pay has become a critical payment rail, moving lifetime GMV past $400 billion, solidifying Shopify's position in the e-commerce environment.
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported earnings per share of $‑0.84 for the quarter ended June 30, 2026, beating the consensus forecast of $‑1.02.
Artivion, Inc. (NYSE: AORT) reported a strong revenue figure of $125.8 million for Q2 2026, marking an 11% increase from $113.0 million in the same quarter of 2025. This outperformance highlights Artivion's ability to exceed analysts' expectations, as reflected by a comparative anchor showing …
Caring Brands, Inc. (NASDAQ: CABR) announced it now holds five U.S. patents that protect its innovative Hair Enzyme Booster and Photocil platforms, which target a combined market opportunity exceeding $20 billion. This news comes at a time when shares are up 61% year-to-date, emphasizing …
Please wait processing your request...